Posted Oct. 22, 2009 at 9:55 a.m.

Premium Lock Delay in H1N1 vaccine production could boost BioCryst

Published: 2009-10-22 09:55:15
Updated: 2009-10-22 09:55:15

BioCryst BioCryst

Durham-based company is developing an antiviral drug that can be delivered intraveneously....

Read More
Read More

Copyright 2014 by WRAL.com and the Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll